INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors
NCT04436679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 342
Last updated 2025-03-30
Summary
The study is particularly innovative as it will accurately analyze the microscopic characteristics of the stroma, tumor budding and mucin expression in adenocarcinomas of the pancreas, using a comparative approach of long-survivor/short-survival patients.
Conditions
- Pancreas Cancer
- Pancreatic Adenocarcinoma
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Principal Investigators
-
Emmanuelle Leteurtre, MD,PhD · University Hospital, Lille
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-02
- Primary Completion
- 2025-02-22
- Completion
- 2025-02-22
Countries
- France
Study Locations
More Related Trials
-
CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer
NCT04560270 ·Status: COMPLETED ·Phase: NA
-
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
NCT05356039 ·Status: RECRUITING
-
PAncreas Borderline and Locally Advanced Snapshot Study
NCT05470738 ·Status: UNKNOWN
-
Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer
NCT03435536 ·Status: COMPLETED ·Phase: NA
-
Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas
NCT05234450 ·Status: UNKNOWN
-
Diffusion MRI for Pancreatic Adenocarcinoma
NCT02896946 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable
NCT02818907 ·Status: COMPLETED ·Phase: NA
-
Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
NCT02934984 ·Status: UNKNOWN
-
Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC
NCT03032913 ·Status: COMPLETED
-
A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer
NCT00149578 ·Status: UNKNOWN ·Phase: PHASE2
-
Early Recurrence After Surgery for Pancreatic Cancer
NCT07241676 ·Status: ENROLLING_BY_INVITATION
-
Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel
NCT06043921 ·Status: RECRUITING
-
A Study of Pancreatic Cancer in Xenografts From Liver Metastases
NCT01774643 ·Status: COMPLETED
-
Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
NCT05871164 ·Status: RECRUITING
-
A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC
NCT04726956 ·Status: COMPLETED
-
Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.
NCT06397846 ·Status: RECRUITING ·Phase: NA
-
Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy
NCT04466189 ·Status: ENROLLING_BY_INVITATION
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer
NCT06144762 ·Status: RECRUITING ·Phase: NA
-
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
NCT02869802 ·Status: RECRUITING
-
A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS
NCT05621824 ·Status: NOT_YET_RECRUITING
-
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
NCT04281511 ·Status: COMPLETED
-
Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples
NCT04246710 ·Status: ACTIVE_NOT_RECRUITING
-
Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer
NCT05201729 ·Status: UNKNOWN
-
Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients
NCT05380414 ·Status: RECRUITING ·Phase: NA